Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
A Phase 3 Randomized Study of Loncastuximab Tesirine Combined with Rituximab Versus Immunochemotherapy in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)
NCT Number:
NCT04384484
Phase:
III
Protocol Type:
Treatment
Age Group:
Adults
Disease Sites:
Non-Hodgkin's Lymphoma
Study Objectives:
The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemotherapy.
Study Documents
(MUSC NetID required for document access)